BioXcel Therapeutics, Inc. (BTAI) Social Stream



BioXcel Therapeutics, Inc. (BTAI): $18.93

0.78 (+4.30%)

POWR Rating

Component Grades

Momentum

B

Stability

F

Sentiment

Quality

C

Add BTAI to Watchlist
Sign Up

Industry: Medical - Pharmaceuticals

Industry

D

Ranked

#151 of 167

in industry

BIOXCEL THERAPEUTICS INC (BTAI) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering BTAI.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 6 $140 $75 $101.375 $18.15 458.54%
2021-12-16 7 $140 $75 $101.375 $18.15 458.54%
2022-01-13 7 $140 $73 $99.75 $18.15 449.59%
2022-02-01 7 $140 $73 $99.428 $18.15 447.81%
2022-03-10 6 $140 $73 $99.428 $18.15 447.81%
2022-03-18 6 $130 $73 $98.5 $18.15 442.7%
2022-04-06 5 $130 $73 $98.5 $18.15 442.7%
2022-04-08 5 $130 $75 $97.714 $18.15 438.37%
2022-04-14 4 $134 $76 $102.166 $18.15 462.9%
2022-04-25 4 $134 $76 $101.833 $18.15 461.06%
2022-05-09 4 $134 $62 $90.5 $18.15 398.62%
2022-05-10 4 $134 $20 $76.833 $18.15 323.32%
2022-05-13 4 $134 $20 $76.571 $18.15 321.88%
2022-05-23 4 $110 $20 $73.142 $18.15 302.99%
2022-06-08 4 $110 $20 $71.714 $18.15 295.12%
2022-07-07 5 $110 $19 $62.428 $18.15 243.96%
2022-08-13 5 $110 $19 $61.571 $18.15 239.23%
2022-09-17 5 $90 $19 $58 $18.15 219.56%
2022-11-16 7 $85 $18 $52.625 $18.15 189.94%
2022-12-01 8 $85 $16 $48.555 $18.15 167.52%
2022-12-15 8 $85 $16 $49.222 $18.15 171.2%
2023-01-03 8 $82 $16 $47.888 $18.15 163.85%
2023-01-26 8 $82 $20 $49 $18.15 169.97%
2023-01-30 8 $78 $20 $48.555 $18.15 167.52%
2023-02-08 8 $78 $20 $48.777 $18.15 168.74%
2023-02-21 8 $79 $20 $51 $18.15 180.99%
2023-03-09 8 $79 $20 $51 $18.15 180.99%
2023-03-10 8 $79 $22 $51.222 $18.15 182.21%
2023-03-21 8 $78 $22 $49.666 $18.15 173.64%
2023-03-31 8 $75 $22 $49.333 $18.15 171.81%
2023-05-08 8 $75 $22 $49 $18.15 169.97%
2023-05-10 8 $75 $22 $51.444 $18.15 183.44%
2023-05-11 8 $75 $24 $51.666 $18.15 184.66%
2023-05-30 8 $75 $24 $51.555 $18.15 184.05%

The Trend in the Analyst Price Target


Over the past 26 months, BTAI's average price target has gone down $53.63.

BTAI reports an average of 177.17% for its upside potential over the past 51 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-08-09 5 110 19 61.571 15.36 300.85%
2023-02-08 8 78 20 50.333 33.24 51.42%
2023-02-21 8 79 20 51.000 31.86 60.08%
2023-03-22 8 75 22 49.333 17.83 176.69%
2023-05-11 8 75 24 51.666 27.07 90.86%

BTAI Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 6 0 2 0 0 8

The Trend in the Broker Recommendations


BTAI's average broker recommendation rating worsened by 0.5 over the prior 52 weeks.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BTAI as an investment opportunity.

  • In terms of how BIOXCEL THERAPEUTICS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 3414.28% of that group.
  • In the context of all US stocks, BIOXCEL THERAPEUTICS INC's variance in analysts' estimates is lower than -3203.58% of them.
  • In the context of stocks in the small market cap category, BIOXCEL THERAPEUTICS INC's average analyst price target is greater than 3677.47% of them.
  • BTAI has a greater number of analysts covering the stock than 2813.84% of stocks in the small market cap category.

In the Pharmaceutical Products industry, MBIO, ACET, and KZIA are the three stocks most similar to BIOXCEL THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.

What is the outlook for BTAI? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6897 seconds.